The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
Külp, Marius, Siemund, Anna Lena, Larghero, Patrizia, Dietz, Alissa, Alten, Julia, Cario, Gunnar, Eckert, Cornelia, Caye-Eude, Aurélie, Cavé, Hélène, Bardini, Michela, Cazzaniga, Giovanni, De Lorenzo, Paola, Valsecchi, Maria Grazia, Diehl, Laura, Bonig, Halvard, Meyer, Claus, Marschalek, Rolf
Published in iScience (15.07.2022)
Published in iScience (15.07.2022)
Get full text
Journal Article
Implication of ICOSLG on Relapse in Infant T(4;11) Acute Lymphoblastic Leukemia
Külp, Marius, Siemund, Anna Lena, Meyer, Claus, Larghero, Patrizia, Dietz, Alissa, Alten, Julia, Cario, Gunnar, Caye-Eude, Aurélie, Cavé, Hélène, Bardini, Michela, De Lorenzo, Paola, Cazzaniga, Giovanni, Diehl, Laura, Bonig, Halvard, Marschalek, Rolf
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article